JACOBIO-B (01167.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec22

AstraZeneca's Involvement in Jiakang KRAS Inhibitor Project Shifts Pharmaceutical Industry Competition Landscape

00:50

Dec2

JAKSION BIOSCIENCE SUBSIDIARY RECEIVES FIRST PAYMENT FROM HISON CAPITAL

04:40

Nov30

J 科思-B publishes KRAS G12C inhibitor combination therapy clinical trial results

23:49

Nov13

JACOBIOTECH-B repurchased 72,000 shares for HKD 498,300

11:29

Nov11

JAKSON BIOSCIENCE REPUCHASED 72,000 SHARES FOR HKD 482,300

10:31

Nov5

J 科思-B repurchased 66,000 shares for HK$463,000

10:59

Schedules & Filings

Schedules

Filings

Aug29

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 24.99 M, Net Income -32.29 M, EPS -0.0417

Mar19

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 82.83 M, Net Income 7.098 M, EPS 0.0091

Aug30

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Net Income -90.83 M, EPS -0.1169

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More